{
    "organizations": [],
    "uuid": "2a9a61833c0cf88e4024008bdde0f774aaa7af70",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-alnylam-pharmaceuticals-reports-q1/brief-alnylam-pharmaceuticals-reports-q1-loss-per-share-of-1-41-idUSASC09ZMI",
    "ord_in_thread": 0,
    "title": "Alnylam Pharmaceuticals Reports Q1 Loss Per Share Of $1.41",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3 (Reuters) - Alnylam Pharmaceuticals Inc:\n* ALNYLAM PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND HIGHLIGHTS RECENT PERIOD ACTIVITY\n* Q1 NON-GAAP LOSS PER SHARE $1.22\n* Q1 REVENUE VIEW $33.6 MILLION — THOMSON REUTERS I/B/E/S * Q1 EARNINGS PER SHARE VIEW $-1.47 — THOMSON REUTERS I/B/E/S\n* ALNYLAM PHARMACEUTICALS - REMAINS ON TRACK TO END 2018 WITH ABOUT $1.0 BILLION OF CASH, CASH EQUIVALENTS, AMONG OTHERS\n* NOW EXPECTS ITS 2018 ANNUAL NON-GAAP RESEARCH AND DEVELOPMENT EXPENSES TO BE IN RANGE OF $420 MILLION TO $460 MILLION Source text for Eikon:\nOur ",
    "published": "2018-05-04T04:27:00.000+03:00",
    "crawled": "2018-05-04T16:37:06.005+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "alnylam",
        "pharmaceutical",
        "inc",
        "alnylam",
        "pharmaceutical",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "highlight",
        "recent",
        "period",
        "activity",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "alnylam",
        "pharmaceutical",
        "remains",
        "track",
        "end",
        "billion",
        "cash",
        "cash",
        "equivalent",
        "among",
        "others",
        "expects",
        "annual",
        "research",
        "development",
        "expense",
        "range",
        "million",
        "million",
        "source",
        "text",
        "eikon"
    ]
}